학술논문

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial
Document Type
Article
Source
In: Rheumatology and Therapy. (Rheumatology and Therapy, June 2024, 11(3):617-632)
Subject
Language
English
ISSN
21986584
21986576